Potentials of nivolumab in the treatment of refractory Hodgkin’s lymphoma: literature review and authors’ own observation
- Autores: Kichigina M.Y.1, Demina E.A2, Tumyan G.S1, Osmanov E.A3, Zeynalova P.A1
-
Afiliações:
- N.N. Blokhin National Medical Research Center of Oncology
- National Medical and Surgical Center N.I. Pirogov
- Sechenov First Moscow State Medical University (Sechenov University)
- Edição: Nº 12 (2018)
- Páginas: 33-38
- Seção: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/295797
- DOI: https://doi.org/10.18565/pharmateca.2018.12.33-38
- ID: 295797
Citar
Texto integral
![Acesso aberto](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_open.png)
![Acesso é fechado](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_unlock.png)
![Acesso é fechado](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Resumo
Palavras-chave
Texto integral
![Acesso é fechado](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Sobre autores
Mariya Kichigina
N.N. Blokhin National Medical Research Center of Oncology
Email: kitchmar@mail.ru
MD, Oncologist, Department of Chemotherapy of Hemoblastosis, Division of Hematology and Bone Marrow Transplantation
E. Demina
National Medical and Surgical Center N.I. PirogovDepartment of Hematology and Cell Therapy, Institute of Advanced Medical Studies
G. Tumyan
N.N. Blokhin National Medical Research Center of Oncology
E. Osmanov
Sechenov First Moscow State Medical University (Sechenov University)
P. Zeynalova
N.N. Blokhin National Medical Research Center of Oncology
Bibliografia
- Hodgkin T. On some morbid experiences of the absorbent glands and spleen. Med. Chir. Trans. 1832;17:69-97
- Weiss L.M., Chan J.K.C., MacLennan K., Warnke R.A. Pathology of classical Hodgkin's disease. In: P.M. Mauch, J.O. Armitage, V. Diehl, R.T Hoppe, L.M. Weiss, (eds). Hodgkin's disease. USA: Lippencott Williams & Wilkins. Philadelphia. Pennsylvania. 1999:101-20.
- Kanzler H., Kuppers R., Hansmann M.L., Rajewsky K. Hodgkin and Reed-Sternberg cell in Hodgkin's disease represent the outgrowth of a dominant tumor clone deriver from (crippled) germinal center B. cell. J. Exp. Med. 1996;184:1495-505.
- Kuppers R., Rajewsky K. The origin of Hodgkin and Reed- Sternberg cell in Hodgkin's disease. Ann. Rev. Immunol. 1998;16:471-93.
- Weber-Matthiesen K., Deerberg J.U., Poetsch M., et. al. Numerical chromosome aberrations are present within the CD30+ Hodgkin and Reed-Sternberg cell in 100% of analyzed cases of Hodgkin's disease. Blood. 1995;86: 1464-68.
- Green M.R., Monti S., Rodig S.J., et al. Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma. Blood. 2010;116:3268-77. doi: 10.1182/blood-2010-05-282780.
- Rui L., Emre N.C., Kruhlak M.J., et al. Cooperative epigenetic modulation by cancer amplicon genes. Cancer Cell. 2010;18:590-605. Doi: 10.1016/j. ccr.2010.11.013.
- Wang C., Thudium K.B., Han M., et al. In vitro characterization of the anti-PD-1 antibody nivolumab, bms-936558, and in vivo toxicology in non-human primates. Cancer Immunol. Res. 2014;2:846-56. doi: 10.1158/2326-6066.CIR- 14-0040.
- Carey C.D., Gusenleitner D., Lipschitz M., et al. Topological analysis reveals a PD-L1 associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma. Blood. 2017;130(22):2420-30. doi: 10.1182/blood-2017-03-770719.
- Pardoll D.M. The blockade of immune checkpoints in cancer immunotherapy Nat. Rev. Cancer 2012;12: 252-64. doi: 10.1038/nrc3239.
- Ribas A. Releasing the Brakes on Cancer immunotherapy. N. Engl. J. Med. 2015;373:1490 2. doi: 10.1056/NEJMp1510079
- Инструкция по медицинскому применению препарата ОПДИВО® от30.07.2018
Arquivos suplementares
![](/img/style/loading.gif)